ZERO is committed to full transparency in supporting pioneering scientific research. Each year, 15% of our verified profits is entrusted to Infinity Inc., advancing life-saving innovations for premature and newborn infants.

Founded in July 2025, ZERO will publish its first annual report following the conclusion of its inaugural financial year. Customers may view our Scientific Impact Report at the bottom of our website for full details.